Skip to main content
Clinical Trials/NCT03667352
NCT03667352
Completed
Phase 4

Efficacy Of Scalp Block And Ultrasound Guided TAP Block With Clonidine As Adjuvant To Ropivacaine Versus Intravenous Fentanyl On Intraoperative Hemodynamics And Perioperative Analgesia In Abdominal Bone Flap Cranioplasties: A Prospective, Randomised, Double Blind Study

Dhritiman Chakrabarti1 site in 1 country60 target enrollmentJuly 15, 2017

Overview

Phase
Phase 4
Intervention
Unilateral Scalp Block
Conditions
Condition: Abdominal Bone Flap Cranioplasty; Focus of Study: Perioperative Analgesia
Sponsor
Dhritiman Chakrabarti
Enrollment
60
Locations
1
Primary Endpoint
Difference in Postoperative Rescue Analgesia requirement between groups
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study assesses efficacy of scalp block and Ultrasound guided transverse abdominis plane (TAP) block with 1µg/kg clonidine as adjuvant to 0.2% ropivacaine versus intravenous fentanyl (0.1µg/kg/hr) on intraoperative hemodynamics and perioperative analgesia in abdominal bone flap cranioplasties (ABFC).

Detailed Description

Scalp blocks with local anaesthetic agents along with general anaesthesia provides intraoperative and postoperative analgesia by blunting the hemodynamic responses to noxious stimuli. The transversus abdominis plane "TAP" block, a regional anaesthesia technique that provides analgesia following abdominal surgery. It involves a single large bolus injection of local anaesthetic into an anatomical space between the internal oblique and transversus abdominis muscles. Ropivacaine is less cardio toxic, less arrhythmogenic, less toxic to central nervous system (CNS) than bupivacaine, and it also has intrinsic vasoconstrictor property. Clonidine is an alpha-2 receptor agonist, which has a known property of reducing requirement of analgesics in the perioperative period. This study aimed to assess the efficacy of scalp block and TAP block with 1µg/kg clonidine as adjuvant to 0.2% ropivacaine versus intravenous fentanyl (0.1µg/kg/hr) on intraoperative hemodynamics and perioperative analgesia in abdominal bone flap cranioplasties.

Registry
clinicaltrials.gov
Start Date
July 15, 2017
End Date
May 15, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Dhritiman Chakrabarti
Responsible Party
Sponsor Investigator
Principal Investigator

Dhritiman Chakrabarti

Assistant Professor

National Institute of Mental Health and Neuro Sciences, India

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing Abdominal bone flap replacement.

Exclusion Criteria

  • Motor and comprehensive aphasia,
  • Disoriented mental state or Inability to follow commands.
  • Hypersensitivity to amide local anesthetics,
  • Bone flap site infection
  • Coagulation disorders

Arms & Interventions

Scalp & TAP Block (Group T)

Group T received 0.2% Ropivacaine + clonidine 1µg/kg mixture, for ipsilateral scalp block (10ml),TAP block under USG guidance (20ml) and intravenous saline 0.1ml/kg/hr (sham infusion) for continuous infusion.

Intervention: Unilateral Scalp Block

Scalp & TAP Block (Group T)

Group T received 0.2% Ropivacaine + clonidine 1µg/kg mixture, for ipsilateral scalp block (10ml),TAP block under USG guidance (20ml) and intravenous saline 0.1ml/kg/hr (sham infusion) for continuous infusion.

Intervention: Transversus abdominis plane block

Intravenous Fentanyl (Group C)

Group C received saline, for ipsilateral scalp block (10ml) and TAP block under USG guidance (20ml) and I.V fentanyl 1 µg/kg/hr as analgesic.

Intervention: Intravenous Fentanyl

Outcomes

Primary Outcomes

Difference in Postoperative Rescue Analgesia requirement between groups

Time Frame: Measured at 1, 6 and 24 hours postoperatively.

Postoperative rescue analgesia (Inj. paracetamol 1gm I.V) if patient reported pain measured by visual analogue score was ≥ 4. Visual analogue scale (VAS) is a self reported score for estimation of pain which ranges between 1 (no pain) to 10 (worst possible pain). VAS score interpretation: No pain - 1, Mild pain \<4, Moderate pain 4-7, Severe pain \>7, Worst possible pain =10.

Secondary Outcomes

  • Difference in intraoperative trend of Heart rate between groups(Measured at 10, 20, 30, 40, 50, 60, 90, 120, 150, 180 minutes after anaesthesia induction.)
  • Difference in intraoperative trend of Systolic blood pressure between groups(Measured at 10, 20, 30, 40, 50, 60, 90, 120, 150, 180 minutes after anaesthesia induction.)
  • Difference in intraoperative trend of Diastolic blood pressure between groups(Measured at 10, 20, 30, 40, 50, 60, 90, 120, 150, 180 minutes after anaesthesia induction.)
  • Difference in patient reported postoperative pain(Measured at 1, 6 and 24 hours postoperatively.)

Study Sites (1)

Loading locations...

Similar Trials